Navigation Links
,,Multi-Drug Therapy Found To Be More Effective in Lowering B.P,,

Researchers from the University of Florida College of Medicine designed a randomized trial to compare two different treatments for hypertension // in older patients. Researchers say most patients require more than one medication to control their blood pressure, so this study was set up to look at multidrug strategies rather than individual drugs. The study found patients had similar outcomes when they took beta-blocker therapy or a calcium antagonist-based therapy.

The research included 22,576 hypertensive patients with coronary artery disease. The study was conducted over five years at 862 sites in 14 countries. The blood pressure goals were less than 140 millimeters of mercury (systolic) and less than 90 millimeters of mercury (diastolic). The goals for patients with diabetes or renal impairment were less than 130 millimeters of mercury (systolic) and less than 85 millimeters of mercury (diastolic). The patients were treated with a calcium antagonist strategy (CAS) or a non-calcium antagonist strategy (NCAS).

Researchers reported that after two years the blood pressure goals that were achieved were similar between the two groups. In the CAS patients, 65 percent of patients achieved the systolic goal compared with 64 percent of the patients in the NCAS group. Similarly, 88.5 percent of the CAS patients reached the diastolic goal and 88.1 of the NCAS patients reached the desired diastolic goal. There was also no significant difference in the number of deaths, heart attack or strokes that occurred in the two groups.

Researchers conclude this study supports the use of either strategy to lower blood pressure in patients with coronary artery disease. They also say the study shows that lower targets for blood pressure control can be achieved by using a multidrug strategy.
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Multi Drug Therapy Found More Effective Lowering

(Date:7/2/2015)... ... July 02, 2015 , ... Facial plastic surgery is ... There is an art and science that goes into successful facial reconstruction and ... facial features and lives of more than 2,500 satisfied facelift and neck lift ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies are now ... Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation & Physical ... conservative treatment of back, hip, knee and shoulder pain as well as sports ...
(Date:7/2/2015)... ... July 02, 2015 , ... Scientists at the University ... through five federal grants to study a group of related mosquito-borne viruses. The ... , The research will be conducted in the Regional Biocontainment Laboratory (RBL) at ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman Digital Anatomy, ... release of their flagship product, 3D Tooth Atlas, version 7.6. This release delivers ... new tutorial videos. This latest release of the 3D Tooth Atlas offers a ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
Breaking Medicine News(10 mins):Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3
... Feb. 19 Wyeth (NYSE: WYE ),announced today ... Court,for Baltimore City in Baltimore, Maryland, has granted Wyeth,s ... al. v. Sigma Aldrich, Inc.,et al -- an alleged ... vaccines caused him to become autistic., Previously, the ...
... of patients with schizophrenia also tend to occur in ... Conte Center for the Neuroscience of Mental Disorders at ... abnormalities were found in the brain,s thalamus. , The ... schizophrenia and their non-affected siblings and compared the scans ...
... or obese have lower concentrations of prostate-specific antigen (PSA) ... a new study led by Duke University Medical Center ... concentrations found in obese and overweight men with prostate ... values for heavier patients, and to encourage those patients ...
... CHICAGO, Feb. 19 The following release was,issued ... Chicago Dental Society (CDS) recently polled more than 300,dentists ... seeking,braces, and how the current presidential candidates, smiles rate., ... one of the largest,displays of dental products in North ...
... Snack or Condiment is a Healthy Choice ... ... a food,quandary with observances of both Heart-Healthy Month and National Snack,Food Month. ... meal times; unfortunately, their snack,choices are not always healthy ones. One solution ...
... clinicians from the Indiana University School of Medicine and ... and clinic as they debut the second generation of ... developed and extensively tested over the past 7 years, ... two groups -- patients with cognitive disorders such as ...
Cached Medicine News:Health News:Wyeth Wins Thimerosal-Autism Case in Maryland Court 2Health News:Wyeth Wins Thimerosal-Autism Case in Maryland Court 3Health News:Siblings of schizophrenia patients display subtle shape abnormalities in brain 2Health News:Overweight and obese men have lower PSA values, even before they get prostate cancer 2Health News:New Guacamole 100-Calorie Packs - The Solution for Clashing February Holidays 2Health News:Merging discovery with therapy: Second generation memory care debuts 2Health News:Merging discovery with therapy: Second generation memory care debuts 3
(Date:7/2/2015)... Minolta, Inc. (Konica Minolta) ( Tokyo : ... Ltda., an X-ray system equipment manufacturer based in Minas ... healthcare sales company, Konica Minolta Healthcare do ... market investment and growth With ... healthcare technical advancements and efficiencies are required. Aging and ...
(Date:7/2/2015)... 2, 2015 ALPINION MEDICAL SYSTEMS Co., Ltd., ... ultrasound system. Developed to enhance user experience and patient ... 15 EX produces superb image quality. With advanced imaging ... health, general imaging, and shared service applications. ... the renowned E-CUBE Series, the E-CUBE 15 EX provides ...
(Date:7/2/2015)... --  Wilson Therapeutics AB , a privately-held biopharmaceutical company, ... board of directors. The appointment was approved by the ... "We are delighted to welcome Hans to ... CEO of Wilson Therapeutics. "Hans brings significant global biopharmaceutical ... his contributions to the Company." Hans Schikan ...
Breaking Medicine Technology:Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
... WARRINGTON, Pa., March 7, 2012  Discovery Laboratories, Inc. (NASDAQ: ... to advancing a new standard in respiratory critical care, ... 10 a.m. EST to discuss its March 6th announcement ... for the prevention of Respiratory Distress Syndrome (RDS) in ...
... 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or ... leading pharmaceutical company specializing in the development, manufacturing, ... in China, today reported unaudited financial results for ... 2011. Highlights , ...
Cached Medicine Technology:Media Alert: Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN® (lucinactant) 2Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 2Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 3Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 4Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 5Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 6Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 7Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 8Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 9Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 10Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 11Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 12Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 13Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 14Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Full Year 2011 Results 15
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... ELISA test for Clostridium difficile antigen that ... sensitivity. That means the laboratory can quickly, ... negatives - which can represent up to ... the organism - and be sure that ...
... Tox A/B II test is also available ... device which greatly reduces the hands-on time ... A/B II testing. The Fecal-Quik-Prep device is ... reduces the amount of hands-on time required ...
Medicine Products: